Journals / Van Tıp Dergisi / 2014 / Cilt: 21 - Sayı: 1

T-cell lymphoblastic lymphoma presented with empyema: A case report

Ampiyem ilelenfoblastikprezente olan t-hücreli lenfoma: Olgu sunumu

Pages
40–43
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This case was presented to emphasize that pleural effusion is an important entity associated with malignancies, as well as infectious agents.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pleural effusion is the result of the imbalance in the secretion-absorption process in the pleural cavity, caused by both the benign and malignant diseases.
📊
Key Findings & Data:Of all the malignant pleural effusions (MPE), 10% are caused by lymphomas (1).
💡
Conclusion & Impact:Conclusion: This case was presented to emphasize that pleural effusion is an important entity associated with malignancies, as well as infectious agents.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pleural effusion is the result of the imbalance in the secretion-absorption process in the pleural cavity, caused by both the benign and malignant diseases. Although the most commonly encountered etiologies are viral and the bacterial infections, and tuberculosis, it can also be associated with lymphoma or other malignancies. Hodgkin’s (HL) and Non- Hodgkin’s lymphoma (NHL)'s are malignant tumors arising from lymphatic tissue. These tumors have varying pathology, immunology, and response to treatment. The prognosis depends on the histological type, the stage, and the other clinical and pathological parameters. The histological diagnosis is important in determining the appropriate treatment approach. Malignancy is an important factor in the etiology of exudative pleural effusions. Of all the malignant pleural effusions (MPE), 10% are caused by lymphomas (1). Especially cases of empyema associated with lymphoma with a delayed diagnosis are rarely described in the literature. In this article, we report a case of lymphoma, which was admitted with the diagnosis of empyema and the lymphoma was diagnosed secondarily. Conclusion: This case was presented to emphasize that pleural effusion is an important entity associated with malignancies, as well as infectious agents.

Özet

Özet Plevral efüzyon, plevral boşluktaki sekresyon-absorpsiyon dengesinin bozulması sonucu oluşur. Benign ve malign hastalıklar plevral efüzyona yol açar. Sıklıkla viral, bakteriel ve tüberküloza bağlı gelişmesine rağmen lenfoma ve malignitelerde de görülebilir. Hodgkin (HL) ve Non-Hodgkin lenfoma (NHL)’lar lenf dokusundan kaynaklanan malign tümörlerdir. Bu tümörlerin patolojisi, immünolojisi ve tedavi yanıtı farklılıklar gösterir. Hastalığın prognozu histolojik tipine, evresine, diğer klinik ve patolojik parametrelere bağlıdır. Histolojik tanı uygun tedavi yaklaşımının belirlenmesinde önemlidir. Eksudatif plevral efüzyonların etyolojisinde malignite önemli nedenlerden biridir. Malign plevral efüzyon (MPE)’ lara lenfoma %10 oranında sebep olmaktadır. Özellikle de ampiyem gelişecek kadar geciken lenfoma olgularına literatürde çok az rastlanmaktadır. Bu yazımızda ampiyem tanısıyla yatırılan ve yapılan ileri tetkiklerinde lenfoma tespit edilen bir olgu sunulmaktadır. Plevral efüzyon etyolojisinde enfeksiyon etkenlerinin yanı sıra malignitelerinde önemli olduğunu vurgulamak amacıyla bu olguyu sunduk.

🔖

Cite This Article

ŞEHİTOĞULLARI, A., KAHRAMAN, A., SAYIR, F., ESEN, R., DEMİR, C. (2014). T-cell lymphoblastic lymphoma presented with empyema: A case report. Van Tıp Dergisi, Cilt: 21 - Sayı: 1, 40–43. https://ajindex.com/articles/334135

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Light RW. Pleural Effusions Related to Metatastic Malignancies. Light RW (ed). Pleural Diseases. Lippincott Williams and Wilkins, Philadelphia 2001; 108-134. 2. Batırel H, Yüksel M. Plevral Efüzyona Yaklaşım: Cerrahi perspektif, Türk Toraks Dergisi 2002; 3:13-19. 3. Bayrak MG, Erkan L, Uzun O, Fındık S, Atıcı AG, Özkaya Ş ve ark. Plevral Efüzyonlu 153 Hastanın Değerlendirilmesi. Solunum Hastalıkları 2006; 17:66-72. 4. Yi JH, Kim JH, Baek KK, Lim T, Lee DJ, Ahn YC, et al. Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma. Ann Oncol 2011; 22(7):1636- 1643. 5. Conner BD, Lee CG, Branca P, Rogers JT, Rodriguez RM, Light RW. Variations in pleural fluid WBC count and differential couts with different sample containers and different methods. Chest 2003; 123(4):1181-1187. 6. Ünlü M, Şahin Ü, Akkaya A. Plevral efüzyonların etiyolojisinin araştırılması. Solunum Hastalıkları 2001; 12:212-215. 7. Marel M, Stastny B, Melínová L, Svandová E, Light RW. Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990. Chest 1995; 107(6):1598-1603. 8. Ko OB, Lee DH, Kim SW, Lee JS, Kim S, Huh J, et al. Clinicopathologic characteristics of T- cell non-Hodgkin's lymphoma: a single institution experience. Korean J Intern Med 2009; 24(2):128-134. 9. Sezer CO, Sönmez OS, Saka D, Ciftçi B, Sipit T. The features of cases of intrathoracic lymphomas. Tuberk Toraks 2003; 51(2):183- 189. 10. Berkman N, Breuer R, Kramer MR, Polliack A. Pulmonary involvement in lymphoma. Leuk Lymphoma 1996; 20(3-4):229-237.